CCEL
AMEX · Health Care
Cryo-Cell Intl Inc
$3.60
+0.05 (+1.41%)
Financial Highlights (FY 2026)
Revenue
30.99M
Net Income
389.9K
Gross Margin
75.1%
Profit Margin
1.3%
Rev Growth
+3.5%
D/E Ratio
0.45
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 75.1% | 75.1% | 58.0% | 58.0% |
| Operating Margin | 10.9% | 9.8% | 14.0% | 13.9% |
| Profit Margin | 1.3% | 1.2% | 13.7% | 12.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 30.99M | 29.96M | 7.57M | 7.87M |
| Gross Profit | 23.29M | 22.51M | 4.39M | 4.56M |
| Operating Income | 3.37M | 2.93M | 1.06M | 1.09M |
| Net Income | 389.9K | 339.2K | 1.04M | 986.8K |
| Gross Margin | 75.1% | 75.1% | 58.0% | 58.0% |
| Operating Margin | 10.9% | 9.8% | 14.0% | 13.9% |
| Profit Margin | 1.3% | 1.2% | 13.7% | 12.6% |
| Rev Growth | +3.5% | +3.5% | +20.2% | +12.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.08M | 4.08M | 9.02M | 8.61M |
| Total Equity | 9.00M | 9.00M | 15.90M | 15.89M |
| D/E Ratio | 0.45 | 0.45 | 0.57 | 0.54 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 3.85M | 3.53M | 1.71M | 1.80M |
| Free Cash Flow | — | — | 1.30M | 1.03M |